Dr. Andrew Weitz joined the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH as a Program Director in 2017. He supports a variety of trans-NIH and trans-agency initiatives, with a focus on health informatics, digital health, and open science.

Dr. Weitz leads digital health strategy for the Rapid Acceleration of Diagnostics (RADx®) Tech program, which received more than $1.5B from Congress to speed the development and commercialization of point-of-care and home-based diagnostic tests. In this role, Dr. Weitz established the RADx MARS program and MakeMyTestCount.org, which facilitate standardized test result reporting from over-the-counter diagnostics. He has also held leadership roles in other NIH initiatives including Home Test to Treat, REsearching COVID to Enhance Recovery (RECOVER), and Say Yes! COVID Test. In addition, Dr. Weitz is part of the leadership team for Stimulating Peripheral Activity to Relieve Conditions (SPARC), a program focused on electrical stimulation of peripheral nerves for treating various diseases and conditions.

Prior to joining NIH, Dr. Weitz was as a Research Assistant Professor at the University of Southern California Institute for Biomedical Therapeutics, where he investigated novel neuromodulation approaches for treating blindness.

Experience

• Program Director (2017 - present)

  National Institutes of Health

• Assistant Professor of Research (2015 - 2017)

  Institute for Biomedical Therapeutics

  University of Southern California (USC)

• Postdoctoral Scholar (2013 - 2015)

  University of Southern California (USC)

Education

• PhD, Biomedical Engineering (2007 - 2013)

  University of Southern California (USC)

• BS, Computer Engineering (2000 - 2004)

  Penn State University